Prevalence of congenital myopathies in a representative pediatric united states population
β Scribed by Kimberly Amburgey; Nancy McNamara; Lindsey R. Bennett; M. Eileen McCormick; Gyula Acsadi; James J. Dowling
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 279 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The prevalence of congenital myopathies in the United States has not been examined. To address this, we determined the point prevalence of congenital myopathies in a wellβdefined pediatric population from Southeastern Michigan. The overall point prevalence was 1:26,000. Mutations in RYR1 were the most common cause of congenital myopathies at 1:90,000. Our data broadly agrees with estimates from previous European studies and provides the first estimate of the prevalence of congenital myopathies in the United States. Ann Neurol 2011;70:662β665
π SIMILAR VOLUMES
## Background: Limited data is available concerning the sex distribution of various congenital anomaly subtypes. this study investigated sex differences in the prevalence of congenital anomalies, overall and by subtype, using high quality population-based data from the north of england. ## Methods
The prevalence of chronic otitis media with effusion (COME) was investigated in a 4-year retrospective study of a pediatric tracheotomy population followed in the outpatient Tracheotomy-Ventilation Clinic of Children's Hospital of Wisconsin. After exclusions, 83 patients comprised the study populati
## Abstract BACKGROUND: The prevalence of NTDs in the US declined significantly after mandatory folic acid fortification; however, it is not known if the prevalence of NTDs has continued to decrease in recent years relative to the period immediately following the fortification mandate. METHODS: Pop